Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways - PubMed (original) (raw)
. 1999 May 14;274(20):13841-6.
doi: 10.1074/jbc.274.20.13841.
Affiliations
- PMID: 10318790
- DOI: 10.1074/jbc.274.20.13841
Free article
Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
J L Norris et al. J Biol Chem. 1999.
Free article
Abstract
Tumors frequently contain mutations in ras genes, resulting in constitutive activation of Ras-activated signaling pathways. The ultimate targets of these signal transduction cascades are transcription factors required for cellular proliferation. Understanding how constitutive activation of Ras contributes to tumorigenesis requires an understanding of both the signaling pathways that Ras activates and how these pathways in turn regulate gene expression. Gene expression from kappaB sites is enhanced in cells transformed with activated Ras and NF-kappaB activity is required for oncogenic Ras to transform NIH-3T3 and Rat-1 fibroblasts. Both dominant negative and constitutively active components of signaling pathways have been tested for their ability to regulate NF-kappaB. These experiments show that Ras utilizes Raf-dependent and Raf-independent pathways to activate NF-kappaB transcriptional activity, both of which require the stress-activated kinase p38 or a related kinase. In the case of Raf, activation of NF-kappaB by an autocrine factor stimulates kappaB-dependent transcriptional activity.
Similar articles
- Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes.
Flory E, Weber CK, Chen P, Hoffmeyer A, Jassoy C, Rapp UR. Flory E, et al. J Virol. 1998 Apr;72(4):2788-94. doi: 10.1128/JVI.72.4.2788-2794.1998. J Virol. 1998. PMID: 9525598 Free PMC article. - Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ. Koong AC, et al. Cancer Res. 1994 Oct 15;54(20):5273-9. Cancer Res. 1994. PMID: 7923153 - Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S, Pianetti S, Kagan HM, Sonenshein GE. Jeay S, et al. Mol Cell Biol. 2003 Apr;23(7):2251-63. doi: 10.1128/MCB.23.7.2251-2263.2003. Mol Cell Biol. 2003. PMID: 12640111 Free PMC article. - The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade.
Porras A, Santos E. Porras A, et al. Int J Obes Relat Metab Disord. 1996 Mar;20 Suppl 3:S43-51. Int J Obes Relat Metab Disord. 1996. PMID: 8680477 Review. - Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma.
Moon H, Ro SW. Moon H, et al. J Liver Cancer. 2021 Mar;21(1):1-11. doi: 10.17998/jlc.21.1.1. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384270 Free PMC article. Review.
Cited by
- NF-kB in development and progression of human cancer.
Dolcet X, Llobet D, Pallares J, Matias-Guiu X. Dolcet X, et al. Virchows Arch. 2005 May;446(5):475-82. doi: 10.1007/s00428-005-1264-9. Epub 2005 Apr 27. Virchows Arch. 2005. PMID: 15856292 Review. - Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells.
Gupta S, Stuffrein S, Plattner R, Tencati M, Gray C, Whang YE, Stanbridge EJ. Gupta S, et al. Mol Cell Biol. 2001 Sep;21(17):5846-56. doi: 10.1128/MCB.21.17.5846-5856.2001. Mol Cell Biol. 2001. PMID: 11486024 Free PMC article. - The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP, Westerheide SD, Baldwin AS Jr. Ashburner BP, et al. Mol Cell Biol. 2001 Oct;21(20):7065-77. doi: 10.1128/MCB.21.20.7065-7077.2001. Mol Cell Biol. 2001. PMID: 11564889 Free PMC article. - Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.
Sharma V, Dixit D, Koul N, Mehta VS, Sen E. Sharma V, et al. J Mol Med (Berl). 2011 Feb;89(2):123-36. doi: 10.1007/s00109-010-0683-5. Epub 2010 Sep 24. J Mol Med (Berl). 2011. PMID: 20865400
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous